Delivery Order SPE2DB20D1004-SPE2DB25FNFVS

Award Date 3/24/25
Potential Completion Date 3/25/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,934.00, is for the supply of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product. The contract has a firm fixed price and has an ultimate completion date of January 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VEMLIDY 25 MG TABLET, a pharmaceutical product, with a ceiling value of $4,860.39. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET UU 30S. The contract has a ceiling value of $10,386.12 and is a firm fixed-price delivery order, with a completion date of September 4, 2024. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET in 30-count packages. The $3,049.76 firm fixed-price contract has a completion date of September 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for providing a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET in quantities of 30s. The contract has a firm fixed price of $15,874.17 and an ultimate completion date of August 21, 2024. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET (NDC 62923-0736-01) in 30-count packages. The contract has a firm fixed price of $2,607.06 and a period of performance through August 13, 2024. This appears to be a part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which has a potential value...
This $3,255.77 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of VEMLIDY 25 MG TABLET UU 30S, a medical product, to support federal healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,091.55 firm fixed price contract is for the supply of VEMLIDY 25 MG TABLET in 30-count units. The contract has an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,707.16 firm-fixed-price contract is for the supply of VEMLIDY 25 MG TABLET UU 30S, a prescription medication. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET. The contract is a firm fixed-price delivery order with a ceiling value of $7,313.05 and an ultimate completion date of January 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNFVS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEMLIDY 25 MG TABLET in quantities of 30 per package. The contract has a firm fixed price of $2,828.40 and a period of performance through March 25, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have any set-aside designations, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 6/29/25, 12:52 AM